Nature Communications (Nov 2021)

Apoptotic stress-induced FGF signalling promotes non-cell autonomous resistance to cell death

  • Florian J. Bock,
  • Egor Sedov,
  • Elle Koren,
  • Anna L. Koessinger,
  • Catherine Cloix,
  • Désirée Zerbst,
  • Dimitris Athineos,
  • Jayanthi Anand,
  • Kirsteen J. Campbell,
  • Karen Blyth,
  • Yaron Fuchs,
  • Stephen W. G. Tait

DOI
https://doi.org/10.1038/s41467-021-26613-0
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 14

Abstract

Read online

Abstract Damaged or superfluous cells are typically eliminated by apoptosis. Although apoptosis is a cell-autonomous process, apoptotic cells communicate with their environment in different ways. Here we describe a mechanism whereby cells under apoptotic stress can promote survival of neighbouring cells. We find that upon apoptotic stress, cells release the growth factor FGF2, leading to MEK-ERK-dependent transcriptional upregulation of pro-survival BCL-2 proteins in a non-cell autonomous manner. This transient upregulation of pro-survival BCL-2 proteins protects neighbouring cells from apoptosis. Accordingly, we find in certain cancer types a correlation between FGF-signalling, BCL-2 expression and worse prognosis. In vivo, upregulation of MCL-1 occurs in an FGF-dependent manner during skin repair, which regulates healing dynamics. Importantly, either co-treatment with FGF-receptor inhibitors or removal of apoptotic stress restores apoptotic sensitivity to cytotoxic therapy and delays wound healing. These data reveal a pathway by which cells under apoptotic stress can increase resistance to cell death in surrounding cells. Beyond mediating cytotoxic drug resistance, this process also provides a potential link between tissue damage and repair.